Neuronetics, Inc.
For the period ended Dec 31, 2025. Filed Mar 17, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 17, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | | |
|---|---|---|
| By: | /s/ Keith J. Sullivan | |
| | Keith J. Sullivan | |
| | President, Chief Executive Officer and Director | |
| Date: | March 17, 2026 | |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| | | | | |
|---|---|---|---|---|
| Signature | | Title | | Date |
| /s/ Keith J. Sullivan | | President, Chief Executive Officer and Director | | March 17, 2026 |
| Keith J. Sullivan | | (Principal Executive Officer) | | |
| /s/ Steven E. Pfanstiel | | Executive VP, Chief Financial Officer and Treasurer | | March 17, 2026 |
| Steven Pfanstiel | | (Principal Financial and Accounting Officer) | | |
| /s/ Robert A. Cascella | | Director | | March 17, 2026 |
| Robert Cascella | | | | |
| /s/ Sheryl L. Conley | | Director | | March 17, 2026 |
| Sheryl Conley | | | | |
| /s/ Megan R. Rosengarten | | Director | | March 17, 2026 |
| Megan Rosengarten | | | | |
| /s/ Sasha S. Cucuz | | Director | | March 17, 2026 |
| Sasha Cucuz | | | | |
| /s/ Glenn P. Muir | | Director | | March 17, 2026 |
| Glenn Muir | | | | |
| /s/ Avinash N. Amin, M.D. | | Director | | March 17, 2026 |
| Avinash Amin, M.D. | | | | |
Index to Consolidated Financial Statements
| | |
|---|---|
| | Page |
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 185) | F-2 |
| Consolidated Balance Sheets | F-4 |
| Consolidated Statements of Operations | F-5 |
| Consolidated Statements of Changes in Equity | F-6 |
| Consolidated Statements of Cash Flows | F-7 |
| Notes to Consolidated Financial Statements | F-8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.